Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to determine if early parametric positron emission computed tomography is useful to diagnose cardiac prosthetic valve infections.


Clinical Trial Description

In addition to routine examinations (biological and microbiological tests, transesophageal or transthoracic ultrasound, transesophageal or transthoracic ultrasound, and leukocyte scintigraphy) of a parametric acquisition during the positron emission computed tomography parametric acquisition during positron emission computed tomography , this examination being itself planned in a standard way. The definitive diagnosis according to the Duke-Li criteria will be established three months later in a multidisciplinary consultation meeting. The final diagnosis according to the Duke-Li criteria will be made three months later in a multidisciplinary consultation meeting, blinded to the results of the parametric positron emission computed tomography, and with knowledge of the results of the standard positron emission computed tomography and the entire work-up. Results and all the complementary work-up. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05146180
Study type Interventional
Source Centre Henri Becquerel
Contact Mathieu Chastan, MD
Phone +33276673032
Email mathieu.chastan@chb.unicancer.fr
Status Recruiting
Phase N/A
Start date February 24, 2022
Completion date March 1, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT05547607 - Clinical and Diagnostic Features of Endocarditis
Completed NCT00750373 - Early Surgery Versus Conventional Treatment in Infective Endocarditis Phase 4
Recruiting NCT03690076 - Human Cardiac Mitochondria in Acute Endocarditis and Obesity
Terminated NCT01734694 - Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients Phase 4
Terminated NCT00995384 - Cardiac Computed Tomography (CT) Scan Compared to Transesophageal Echocardiogram (TEE) in Endocarditis N/A
Completed NCT04309591 - Cytosorb Therapy in Cardiac Surgery
Recruiting NCT05142891 - Renal Tolerance of Amoxicillin and Cloxacillin Combination
Recruiting NCT05703022 - Early Exercise Training in Patients Following Heart Valve Surgery for Infective Endocarditis. N/A
Completed NCT01431326 - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Completed NCT03377465 - Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis N/A
Recruiting NCT03892174 - Cytokine REmoval in CRitically Ill pAtients Requiring Surgical Therapy for Infective Endocarditis (RECReATE) N/A
Completed NCT03695861 - Contribution of 18F-FDG PET-CT in the Diagnosis and the Detection of Peripheral Emboli of Infectious Endocarditis on Native Valves N/A
Recruiting NCT02759978 - Individualized Diagnosis of Endocarditis and Its Therapy With a Focus on Infected Prosthetic materiAL
Completed NCT00709358 - Diagnosis of Septicaemia by Detection of Microbial DNA in Blood in Severe Infections Phase 4
Terminated NCT03148756 - Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective Endocarditis Phase 2
Enrolling by invitation NCT05156437 - Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL) Phase 4
Recruiting NCT06107309 - Suppressive Antibiotic Therapy for Endocarditis
Completed NCT02251262 - Diagnostic Accuracy of 18FDG-PET-CT for Pacing or Defibrillation Lead Infection N/A
Recruiting NCT03112356 - The Value of 99mTc-Leukoscan® Scintigraphy in the Diagnosis of Infectious Endocarditis on Surgical Materials Phase 4
Completed NCT01375257 - Partial Oral Treatment of Endocarditis Phase 4